At Iowa Weight Loss Specialists, we believe you deserve a weight loss plan that is safe, personalized, and designed for lasting results
Patients report sustained improvements in energy, body composition, recovery, cognitive function, and overall vitality
FDA does not review or evaluate compounded products for safety, effectiveness, or quality
cinerea (B0510) plates and diluted to ~1 10 6 conidiospores/mL in PDB medium (Potato Dextrose Broth, BD)
Now, Lilly recently reported topline results from the ATTAIN-1 phase-3 trial evaluating orforglipron, a once-daily oral glucagon-like-peptide-1 (GLP-1) receptor agonist for adults with obesity or overweight without diabetes
The new medication from Tufts targets a combination of four hormones GLP-1, GIP, glucagon (the counterpart to insulin), and peptide YY, which reduces hunger, slows stomach emptying and may promote fat-burning